Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
Esophageal Cancer Market: What is the Projected CAGR for 2024-2033?
The market size for esophageal cancer has seen rapid expansion in recent years. The size is set to increase from $1.25 billion in 2023 to $1.38 billion in 2024, with a compound annual growth rate (CAGR) of 10.0%. The growth during the historic period is owed to factors such as a higher number of cancer cases, enhancement in healthcare infrastructure, surge in alcohol intake, increased demand for preventive healthcare solutions, and a rise in the incidence of esophageal adenocarcinoma.
The forecast for the esophageal cancer market promises robust growth in the coming years, with a projection to reach $1.94 billion by 2028, fostering a compound annual growth rate (CAGR) of 8.9%. Factors such as the escalating incidence of esophageal cancer, a growing public awareness of healthcare, enhancements in healthcare infrastructure, habitual smoking, and alcohol consumption, along with a rise in esophageal adenocarcinoma cases are influencing this growth. Expected trends for this period involve advances in treatment methodologies, heightened investments in research and development, the rising application of precision medicine, the creation of targeted therapies, an uptick in clinical trials participation, and cooperative efforts among educational institutions, pharmaceutical businesses, and healthcare organizations.
Claim Your Free Sample of the Global Esophageal Cancer Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12637&type=smp
What Are the Primary Drivers Supporting the Growth of the esophageal cancer Market?
The expansion of the esophageal cancer market is anticipated to be driven by a rise in the prevalence of esophageal cancer. This type of cancer damages the esophagus, which is the pipe-like component connecting the throat and stomach. As the occurrence of esophageal cancer intensifies, there will be a growing need for diagnostic techniques like endoscopies, image tests, and biopsies to identify and verify the existence of the disease. For example, records from the National Library of Medicine, a medical library managed by the US government, show that the incidence rate of esophageal adenocarcinoma in individuals between the ages of 40 and 65 is expected to climb from 2.12 per 100,000 people in 2021 to 3.86 per 100,000 people in 2040, as of February 2023. This indicates an 82% growth over a span of 19 years, which corresponds to an annual growth rate of 3.2%. Hence, the upsurge in esophageal cancer is projected to stimulate the esophageal cancer market’s growth.
What Are the Core Segments of the Esophageal Cancer Market?
1) By Type: Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types
2) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users
What Trends Are Paving the Way for Change in the Esophageal Cancer Market?
Acquiring new drug approvals has become a prevalent trend in the esophageal cancer market, acting as a strategic move taken by leading companies to tighten their grip in the marketplace and stay ahead of their competitors. An exemplar of this is Bristol Myers Squibb, a renowned pharmaceutical company from the US, which managed to earn the approval of the US Food and Drug Administration (FDA) for two of its products, namely, Opdivo (nivolumab), an intravenous injection, and a combination of Opdivo plus Yervoy (ipilimumab) in May 2022. These therapies are primarily formulated to treat patients suffering from advanced or metastatic esophageal squamous cell carcinoma (ESCC). This FDA approval was sanctioned post the successful outcome of a Phase 3 clinical trial, showing improved survival rates for patients administered these medications.
Order Now for Fast Delivery of Your Esophageal Cancer Market Report!
https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report
Which Regions Are Leading the Charge in Esophageal Cancer Market Development?
North America was the largest region in the esophageal cancer market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the esophageal cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Esophageal Cancer Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the esophageal cancer market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Esophageal Cancer Market Include
1. Esophageal Cancer Market Executive Summary
2. Esophageal Cancer Market Segments
3. Esophageal Cancer Market Size And Template Market Growth Rate
4. Key Esophageal Cancer Market Trends
5. Major Esophageal Cancer Market Drivers
……
25. Key Mergers And Acquisitions In The Esophageal Cancer Market
26. Top Esophageal Cancer Companies
27. Esophageal Cancer Market Opportunities And Strategies
28. Esophageal Cancer Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Prostate Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report
Thyroid Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report
Urothelial Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/urothelial-cancer-drugs-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
